3,810
Views
5
CrossRef citations to date
0
Altmetric
Editorial

Dual LABA/LAMA bronchodilators in chronic obstructive pulmonary disease: why, when, and how

ORCID Icon, , ORCID Icon & ORCID Icon
Pages 261-264 | Received 06 Dec 2017, Accepted 14 Feb 2018, Published online: 19 Feb 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Luigino Calzetta, Elena Pistocchini, Alfredo Chetta, Paola Rogliani & Mario Cazzola. (2023) Experimental drugs in clinical trials for COPD: artificial intelligence via machine learning approach to predict the successful advance from early-stage development to approval. Expert Opinion on Investigational Drugs 32:6, pages 525-536.
Read now
Fiammetta Danzo, Dejan Radovanovic, Marina Gatti, Marina Saad, Luca Perotto, Elisa Franceschi & Pierachille Santus. (2022) A reappraisal of inspiratory capacity in chronic obstructive pulmonary disease: clinical correlates and role of long-acting muscarinic antagonists and long-acting β2 agonists. Expert Review of Respiratory Medicine 16:6, pages 623-635.
Read now
Luigino Calzetta, Maria Gabriella Matera, Paola Rogliani & Mario Cazzola. (2020) The role of triple therapy in the management of COPD. Expert Review of Clinical Pharmacology 13:8, pages 865-874.
Read now
Maria Gabriella Matera, Carmela Belardo, Michele Rinaldi, Barbara Rinaldi & Mario Cazzola. (2020) New perspectives on the role of muscarinic antagonists in asthma therapy. Expert Review of Respiratory Medicine 14:8, pages 817-824.
Read now
Maria Gabriella Matera, Barbara Rinaldi, Clive Page, Paola Rogliani & Mario Cazzola. (2018) Pharmacokinetic considerations concerning the use of bronchodilators in the treatment of chronic obstructive pulmonary disease. Expert Opinion on Drug Metabolism & Toxicology 14:10, pages 1101-1111.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.